FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083479403> ?p ?o ?g. }

• W2083479403 endingPage "248" @default.
• W2083479403 startingPage "239" @default.
• W2083479403 abstract "Purpose Pyridoxine-dependent epilepsy seizure (PDE; OMIM 266100) is a disorder associated with severe seizures that can be controlled pharmacologically with pyridoxine. In the majority of patients with PDE, the disorder is caused by the deficient activity of the enzyme α-aminoadipic semialdehyde dehydrogenase (antiquitin protein), which is encoded by the ALDH7A1 gene. The aim of this work was the clinical, biochemical, and genetic analysis of 12 unrelated patients, mostly from Spain, in an attempt to provide further valuable data regarding the wide clinical, biochemical, and genetic spectrum of the disease. Methods The disease was confirmed based on the presence of α-aminoadipic semialdehyde (α-AASA) in urine measured by liquid chromatography tandem mass spectrometry (LC-MS/MS) and pipecolic acid (PA) in plasma and/or cerebrospinal fluid (CSF) measured by high performance liquid chromatography (HPLC)/MS/MS and by sequencing analysis of messenger RNA (mRNA) and genomic DNA of ALDH7A1. Key Findings Most of the patients had seizures in the neonatal period, but they responded to vitamin B6 administration. Three patients developed late-onset seizures, and most patients showed mild-to-moderate postnatal developmental delay. All patients had elevated PA and α-AASA levels, even those who had undergone pyridoxine treatment for several years. The clinical spectrum of our patients is not limited to seizures but many of them show associated neurologic dysfunctions such as muscle tone alterations, irritability, and psychomotor retardation. The mutational spectrum of the present patients included 12 mutations, five already reported (c.500A>G, c.919C>T, c.1429G>C c.1217_1218delAT, and c.1482-1G>T) and seven novel sequence changes (c.75C>T, c.319G>T, c.554_555delAA, c.757C>T, c.787 + 1G>T, c.1474T>C, c.1093-?_1620+?). Only one mutation, p.G477R (c.1429G>C), was recurrent; this was detected in four different alleles. Transcriptional profile analysis of one patient's lymphoblasts and ex vivo splicing analysis showed the silent nucleotide change c.75C>T to be a novel splicing mutation creating a new donor splice site inside exon 1. Antisense therapy of the aberrant mRNA splicing in a lymphoblast cell line harboring mutation c.75C>T was successful. Significance The present results broaden our knowledge of PDE, provide information regarding the genetic background of PDE in Spain, afford data of use when making molecular-based prenatal diagnosis, and provide a cellular proof-of concept for antisense therapy application." @default.
• W2083479403 created "2016-06-24" @default.
• W2083479403 creator A5001813953 @default.
• W2083479403 creator A5007582493 @default.
• W2083479403 creator A5019945278 @default.
• W2083479403 creator A5020609349 @default.
• W2083479403 creator A5031327614 @default.
• W2083479403 creator A5031807627 @default.
• W2083479403 creator A5034925695 @default.
• W2083479403 creator A5040246496 @default.
• W2083479403 creator A5041934173 @default.
• W2083479403 creator A5043823692 @default.
• W2083479403 creator A5060854252 @default.
• W2083479403 creator A5070729416 @default.
• W2083479403 creator A5071020579 @default.
• W2083479403 creator A5073454124 @default.
• W2083479403 creator A5073763428 @default.
• W2083479403 creator A5075255886 @default.
• W2083479403 creator A5076973291 @default.
• W2083479403 creator A5081549124 @default.
• W2083479403 creator A5082805678 @default.
• W2083479403 creator A5089995815 @default.
• W2083479403 date "2013-01-25" @default.
• W2083479403 modified "2023-10-18" @default.
• W2083479403 title "Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic option" @default.
• W2083479403 cites W1965346473 @default.
• W2083479403 cites W1975165842 @default.
• W2083479403 cites W1978492529 @default.
• W2083479403 cites W1979719244 @default.
• W2083479403 cites W1981502684 @default.
• W2083479403 cites W2011983240 @default.
• W2083479403 cites W2040756263 @default.
• W2083479403 cites W2057422393 @default.
• W2083479403 cites W2067370987 @default.
• W2083479403 cites W2068834392 @default.
• W2083479403 cites W2079752520 @default.
• W2083479403 cites W2083650794 @default.
• W2083479403 cites W2084235566 @default.
• W2083479403 cites W2108483271 @default.
• W2083479403 cites W2129616125 @default.
• W2083479403 cites W2134367834 @default.
• W2083479403 cites W2135114355 @default.
• W2083479403 cites W2139792545 @default.
• W2083479403 cites W2143163042 @default.
• W2083479403 cites W2156672390 @default.
• W2083479403 cites W2157116018 @default.
• W2083479403 cites W2163274622 @default.
• W2083479403 doi "https://doi.org/10.1111/epi.12083" @default.
• W2083479403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23350806" @default.
• W2083479403 hasPublicationYear "2013" @default.
• W2083479403 type Work @default.
• W2083479403 sameAs 2083479403 @default.
• W2083479403 citedByCount "39" @default.
• W2083479403 countsByYear W20834794032013 @default.
• W2083479403 countsByYear W20834794032014 @default.
• W2083479403 countsByYear W20834794032015 @default.
• W2083479403 countsByYear W20834794032016 @default.
• W2083479403 countsByYear W20834794032017 @default.
• W2083479403 countsByYear W20834794032018 @default.
• W2083479403 countsByYear W20834794032019 @default.
• W2083479403 countsByYear W20834794032020 @default.
• W2083479403 countsByYear W20834794032021 @default.
• W2083479403 countsByYear W20834794032022 @default.
• W2083479403 countsByYear W20834794032023 @default.
• W2083479403 crossrefType "journal-article" @default.
• W2083479403 hasAuthorship W2083479403A5001813953 @default.
• W2083479403 hasAuthorship W2083479403A5007582493 @default.
• W2083479403 hasAuthorship W2083479403A5019945278 @default.
• W2083479403 hasAuthorship W2083479403A5020609349 @default.
• W2083479403 hasAuthorship W2083479403A5031327614 @default.
• W2083479403 hasAuthorship W2083479403A5031807627 @default.
• W2083479403 hasAuthorship W2083479403A5034925695 @default.
• W2083479403 hasAuthorship W2083479403A5040246496 @default.
• W2083479403 hasAuthorship W2083479403A5041934173 @default.
• W2083479403 hasAuthorship W2083479403A5043823692 @default.
• W2083479403 hasAuthorship W2083479403A5060854252 @default.
• W2083479403 hasAuthorship W2083479403A5070729416 @default.
• W2083479403 hasAuthorship W2083479403A5071020579 @default.
• W2083479403 hasAuthorship W2083479403A5073454124 @default.
• W2083479403 hasAuthorship W2083479403A5073763428 @default.
• W2083479403 hasAuthorship W2083479403A5075255886 @default.
• W2083479403 hasAuthorship W2083479403A5076973291 @default.
• W2083479403 hasAuthorship W2083479403A5081549124 @default.
• W2083479403 hasAuthorship W2083479403A5082805678 @default.
• W2083479403 hasAuthorship W2083479403A5089995815 @default.
• W2083479403 hasBestOaLocation W20834794031 @default.
• W2083479403 hasConcept C118552586 @default.
• W2083479403 hasConcept C126322002 @default.
• W2083479403 hasConcept C134018914 @default.
• W2083479403 hasConcept C185592680 @default.
• W2083479403 hasConcept C2776514930 @default.
• W2083479403 hasConcept C2778186239 @default.
• W2083479403 hasConcept C2780026642 @default.
• W2083479403 hasConcept C2780865232 @default.
• W2083479403 hasConcept C515207424 @default.
• W2083479403 hasConcept C55493867 @default.
• W2083479403 hasConcept C71924100 @default.
• W2083479403 hasConcept C98274493 @default.

• next